Autolus Therapeutics plc ADR (NASDAQ:AUTL) traded at $4.00 at close of the session on Friday, April 26, made a downward move of -1.96% on its previous day’s price.
Looking at the stock we see that its previous close was $4.08 . In terms of its 52-week price range, AUTL has a high of $7.45 and a low of $1.61. The company’s stock has lost about -35.90% over that past 30 days.
Autolus Therapeutics plc ADR has a market cap of $696.40 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.05, with the EPS growth for the year raised at -$0.71 for 2024 and -$0.59 for next year. These figures represent 40.80% and 16.90% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $16.67 million, with a high of $50 million. The median projection represents growth squeezing down to 1,190.20% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $36.88 million, or 2,072.00% up from figures reported last year.
On the other hand, looking at the outlook for the AUTL stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of Hold. Long term indicators on average place the stock in the category of 50% Sell.
Looking further, we note the current price level is -21.40% off its SMA20 and -29.81% from its 50-day simple moving average. The RSI (14) is pointing at 22.28 while the volatility over the past week is 6.42% and jumps to 6.62% over the past one month. The beta value is 2.00, while the average true range (ATR) is currently pointing at 0.33.
Coming back to Autolus Therapeutics plc ADR (NASDAQ:AUTL), we note that the average 3-month trading volume was 1.61 million. Current shares outstanding are 174.10 million.
The insiders hold 9.38% of the company’s shares while institutions hold 61.84%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -37.89% down in year-to-date price movement.
